Omnia Family Wealth’s Albany Molecular Research Inc AMRI Stock Holding History

Omnia Family Wealth’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-186	Closed	-$4K	–	726
2017 Q2	$4K	Hold	186	–	–	﹤0.01%	490
2017 Q1	$3K	Hold	186	–	–	﹤0.01%	554
2016 Q4	$3K	Buy	+186	New	+$3.16K	﹤0.01%	567

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Omnia Family Wealth's AMRI Position: Q3 2017 in Review

Omnia Family Wealth sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 186 shares — an estimated $4K sold.

Omnia Family Wealth first reported a position in AMRI in Q4 2016 and held it in 3 quarters. The position peaked at $4K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

Omnia Family Wealth reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
Omnia Family Wealth sold 186 Albany Molecular Research Inc shares in Q3 2017, an estimated $4K.
Omnia Family Wealth first reported a position in Albany Molecular Research Inc in Q4 2016 and held it in 3 quarters.
Omnia Family Wealth's Albany Molecular Research Inc position peaked at $4K in Q2 2017.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Omnia Family Wealth's 13F filing for Q3 2017, filed 14 Nov 2017.